Paediatric Infections Point-Of-Care

NCT03900091 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 351

Last updated 2020-12-16

No results posted yet for this study

Summary

This study aims to identify the aetiology of childhood meningitis in Southwestern Uganda and develop and evaluate new methods for point-of-care diagnosis of childhood meningitis in a low-income setting. A prospective observational study including 600 children aged 0-12 years will be conducted during 1 year in Mbarara, Uganda. We estimate to recruit about 300 children with suspected meningitis (cases), and 300 with non-severe infection age-matched as controls.

Conditions

Interventions

DIAGNOSTIC_TEST

Multiplex PCR assay for meningitis

CSF from cases to be analysed with a FilmArray ME Panel

DIAGNOSTIC_TEST

Multiplex vertical flow microarrray assay for meningitis

CSF from cases will also undergo analysis with a newly developed prototype for point-of-care diagnostic tool for CNS infections identification. The tool is a DNA-based vertical flow microarray technology printed on paper.

DIAGNOSTIC_TEST

Profiling of blood proteins by multi-analyte Profiling technology

Blood from cases and controls to be analysed using Luminex technology to identify protein profiles associated with severe and non-severe infection. Myxovirus protein A (MxA) will also be analysed by the Luminex assay, to associate MxA levels with severe/non-severe infection.

OTHER

Typing and whole genome sequencing

Pathogenic strains isolated from nasopharyngeal swabs from cases and controls will undergo whole genome sequencing (WGS) and typing .

Sponsors & Collaborators

  • Mbarara University of Science and Technology

    collaborator OTHER
  • Science for Life Laboratory

    collaborator UNKNOWN
  • Epicentre Mbarara Research Center

    collaborator UNKNOWN
  • Stockholm South General Hospital

    collaborator OTHER
  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Elias Kumbakumba, MD · Mbarara University of Science and Technology

  • Tobias Alfvén, MD PhD · Karolinska Institutet

Eligibility

Min Age
1 Day
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-07-24
Completion
2020-07-24

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03900091 on ClinicalTrials.gov